rhpiv3cp45
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00308412)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human parainfluenza virus 3Immunity, active
Human parainfluenza virus 3 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rhpiv3cp45
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01254175 | Phase 1 | Dec 1, 2010 | Duke University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01021397 | Phase 1 | Nov 1, 2009 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00308412 | Phase 1 | Jun 1, 2006 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2006 |
| Johns Hopkins University | Academic/Hospital | 2 | 0 | 1 | 2006 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1